Navigation Links
Life Line Screening Data on Peripheral Arterial Disease Validated
Date:3/25/2009

Data from Life Line Screening corroborates research recently presented at the Society of Interventional Radiology's annual scientific meeting: The importance of the ankle-brachial index in identifying high-risk individuals previously thought to be at low-risk for cardiovascular disease was confirmed.

Independence, OH (PRWEB) March 25, 2009 -- An analysis of almost 1 million Life Line Screening participants confirms the findings recently presented at the Society for Interventional Radiology's annual meeting on the importance of the ankle-brachial index to identify individuals previously thought to be at low risk for cardiovascular disease and correctly categorizing them as possibly high-risk.

The findings presented at the conference came from the 1999-2004 National Health and Nutrition Examination Survey (NHANES), a nationally representative cross-sectional survey of the U.S. population. It looked at 6,292 men and women ages 40 and older with no known history of heart disease, stroke, diabetes or atherosclerotic vascular disease. It found that the use of the Ankle ankle-brachial index, a screening for peripheral arterial disease, has the potential to prevent heart attacks in thousands originally thought to be at low risk.

Life Line Screening's data supports these findings. Analyzing data from almost 900,000 participants from 2007, Life Line Screening found that 474,000 would be considered low-risk based on a traditional Framingham score. Of that "low-risk" group, more than 9,000 scored positive for peripheral arterial disease, indicating the presence of subclinical atherosclerosis.

Similar to those in the NHANES study, Life Line Screening participants are traditionally age 50 and older and are asymptomatic.

"We are pleased to see the recent findings presented at the conference reflect our own internal data," says Chief Medical Officer Andrew Manganaro, MD, FACS, FACC. "We have long suspected that the low risk indicated by a Framingham may conceal the true risk as revealed by other screenings such as the ankle-brachial index. We share the researchers' sentiment that correctly identifying risk is crucial to instituting lifestyle changes and medical management before a serious health event occurs or more costly treatment options are necessary."

About Life Line Screening:
Life Line Screening is the nation's leading provider of community-based preventive health screenings and has a primary focus on stroke prevention and the early detection of subclinical atherosclerosis.

Life Line Screening also provides screening for C-reactive protein, another novel risk factor shown to improve risk prediction by the SIR researchers.

###

Read the full story at http://www.prweb.com/releases/Health_Screening/Arterial_Disease/prweb2261784.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. FDA Approves New Roche West Nile Virus Blood Screening Test
2. New lung cancer guidelines oppose general CT screening
3. New Lung Cancer Guidelines Oppose General CT Screening
4. Lung Cancer Alliance Stands Behind CT Screening for Lung Cancer
5. Screening Proposed for Childhood Cholesterol Levels
6. A new technology for cancer screening listens for the signs of cancer
7. Study Questions Genetic Screening for Treatable Diseases
8. Cervical cancer screening: Too many are left unprotected
9. Simple, personalized interventions improve colorectal cancer screening rates
10. Doctors Office Outreach Boosts Colon Cancer Screening
11. Jefferson researchers find personalized interventions key to improving colon cancer screening rates
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Life Line Screening Data on Peripheral Arterial Disease Validated
(Date:6/24/2017)... Tampa, Fla. (PRWEB) , ... June 24, 2017 ... ... Fla., is now offering genetic testing for medications in select Florida and Texas ... of pharmacogenomics. , This new application of genetic testing recognizes the role ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island ... Care Management Alerts and Dashboards, an innovative new service enabling healthcare providers to ... Care Management Alerts and Dashboards provide near real-time data about patients admitted to ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Military Officers Association of America (MOAA) announced ... Veterans Affairs, retired Marine Col. Thomas G. Bowman. , Bowman currently serves as the ... an intimacy with the issues and challenges veterans face with the VA. Following a ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... The Aesthetic ... facelift . Dr. Talei has come up with a proprietary technique that he calls ... lifts tissues that have dropped. For all ages, patients can expect to look refreshed, ...
(Date:6/23/2017)... Santa Monica, CA (PRWEB) , ... June 23, 2017 , ... ... PureLife as the endorsed amalgam separator supplier for CDA members. As part of the ... a reduced price of $99, saving more than $400 off the retail value. This ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... ALTO, Calif. , June 9, 2017 ... device company focused on the design, manufacture, sale and ... the market on the progress of its commercial roll-out ... is now available in more than one hundred (100) ... AeroForm offers a needle-free alternative for ...
(Date:6/7/2017)... , June 7, 2017 Endo International ... June 7, 2017, the Hon. Joseph R. Goodwin ... of West Virginia , entered a ... Inc. Pelvic Repair System Products Liability Litigation (the "MDL") ... MDL cases to provide expert disclosures on specific causation ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: